Open-Label Atomoxetine for Attention-Deficit/Hyperactivity Disorder Symptoms Associated with High-Functioning Pervasive Developmental Disorders
Posey, D.; Weigand, R.; Wilkerson, J.; Maynard, M.; Stigler, K.; McDougle, C.
, Journal of Child and Adolescent Psychopharmacology, Volume 16, Issue 5, p.599-610, (2006)
Layperson Summary
